Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 02, 2018
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 23, 2017
Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non-Small-Cell Lung Cancer.
Journal: Clinical lung cancer
Published: April 05, 2016
Efficacy and Safety Results From a Phase II, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy for Advanced Squamous Cell Non-Small-Cell Lung Cancer.
Journal: Clinical lung cancer
Published: December 09, 2015
Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 11, 2015
Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 23, 2014
Showing 1-6 of 6
Last Updated: 09/26/2026